AXP vs NAGE · P/E 20, rev $21.73B vs P/E 59, rev $61.3M
American Express Company (AXP) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the AXP and NAGE stock pages for the full models.
Not investment advice.